Evogene Reports First Quarter 2025 Financial Results
The original release is unavailable here.
In the deck
Story so far
Earlier from Evogene
- Evogene Schedules First Quarter 2025 Financial Results Release
- ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
- Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
- Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
- Evogene Schedules Fourth Quarter 2024 Financial Results Release
Later from Evogene
- Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
- Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
- Evogene Schedules Second Quarter 2025 Financial Results Release
- Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
- Evogene Reports Second Quarter 2025 Financial Results
Follow Evogene into a list and get an email when it puts out news.
Follow Evogene